An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

A man with multiple sclerosis (MS) is about to undertake a feat of physical and mental endurance. Dominic Shadbolt, 53, from ...

Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was ...

The University of Oregon now has four confirmed international students who have had their visas revoked based on unspecified ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

Christina Applegate revealed her multiple sclerosis diagnosis in August 2021 and has been candid about how the disease ...